QUALITY OF LIFE AND COGNITION IN PATIENTS WITH PARKINSON'S DISEASE DURING THE COVID-19 PANDEMIC

Resumen

Introduction: Restrictive isolation contributes to the containment of the virus, but it also has negative consequences for mental health. This study aimed to assess the quality of life, during the pandemic, in patients with Parkinson's disease (PD), compare it with measures before the pandemic, and identify factors that may be associated with non-compliance with cognitive intervention activities. Methods: The PDQ-39 questionnaire was reapplied in a sample of PD patients previously followed up in rehabilitation program. In addition, a questionnaire to assess the follow-up of cognitive training activities was elaborated. Results: Twenty-two individuals with mean age of 62.72(7.49) years and a mean duration of the disease of 8.7(3.30) years participated in this study. There was a statistically significant difference in the total score of the PDQ-39(p=0.048), as well as in the mobility (p=0.038), stigma (p=0.035), social support(p=0.045), and cognition(p=0.026) dimensions. When analyzing the questionnaire, it was observed that most of the sample was able to follow the guidelines received during the cognitive training group (77.3%), mainly reading activities (41%), games (35%), and applications (35%). However, 77.3% reported worsening cognition, with attention (50%) and memory (34%) being highlighted, as well as sadness, discouragement, and indisposition (72%), anxiety (77.27%), and difficulty falling asleep (68%). A total of 86.36% perceived the need for professional support in mental health. Conclusion: This study showed the impact of the pandemic on individuals with PD, leading to a worse perception of quality of life and subjective complaints related to sleep disturbance, cognitive impairment, and neuropsychiatric symptoms (depression and anxiety).